Delving into the Latest Updates on Coronavirus (Quratis) with Synapse

Overview

Basic Info

Drug Type

asPNA

Synonyms-

Target-

Action-

Mechanism-

Therapeutic Areas

Infectious Diseases

Active Indication

Coronavirus Infections

Inactive Indication-

Originator Organization

Quratis, Inc.

Active Organization

Quratis, Inc.

Inactive Organization-

License Organization-

Drug Highest PhaseDiscovery

First Approval Date-

Regulation-

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has caused a global pandemic since late 2019 that resulted in more than 360 million population infection. Patients with cancers may be at higher risk of infection and severity than those without cancer. Mass vaccination has been carried out, but reinfection and vaccine breakthrough cases still occur. Now, the prime-boost regimen was identified safe and efficient, but the reactogenicity and immunogenicity of prime-boost vaccine strategy in cancer patients were not known.

Start Date11 Feb 2022

Sponsor / Collaborator-

NCT04323839

/ CompletedNot ApplicableIIT

PRIORITY (Pregnancy Coronavirus Outcomes Registry)

PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) is a prospective cohort study of pregnant and recently pregnant women who are: either patients under investigation for COVID-19 or a confirmed case of COVID-19. Data from PRIORITY will be used to evaluate the impact of COVID-19 on the clinical course and pregnancy outcomes of pregnant women and women within 6 weeks of pregnancy.

Start Date20 Mar 2020

Sponsor / Collaborator

The University of California, San Francisco

[+1]

100 Clinical Results associated with Coronavirus (Quratis)

Login to view more data

100 Translational Medicine associated with Coronavirus (Quratis)

Login to view more data

100 Patents (Medical) associated with Coronavirus (Quratis)

Login to view more data

1

Literatures (Medical) associated with Coronavirus (Quratis)

Journal of the Egyptian National Cancer Institute

A case of COVID-19 vaccination during radiotherapy for breast cancer

Article

Author: Jingu, Keiichi ; Kishida, Keita ; Suzuki, Yu ; Teramura, Satoshi ; Takahashi, Noriyoshi ; Takeda, Kazuya

Abstract:

Background:

The coronavirus disease 19 (COVID-19) vaccination has been progressing. The safety of vaccination during radiotherapy is not clear.

Case presentation:

We experienced a patient who received a COVID-19 vaccine during radiotherapy. A 60-year-old woman with breast cancer underwent postoperative radiotherapy. She received two vaccine doses and she suffered from severe vertigo. Her radiotherapy was suspended for several days and the radiotherapy schedule needed to be changed.

Conclusions:

The association between vertigo and vaccination during radiotherapy is not clear. However, if the general condition of patients worsens, suspension of treatment might be necessary. Therefore, attention should be given to COVID-19 vaccination during radiotherapy.

100 Deals associated with Coronavirus (Quratis)

Login to view more data